How Procurement and QA Teams Review a Peptide API Certificate of Analysis

A certificate of analysis is often the first technical document a procurement or QA reviewer sees when evaluating a peptide API supplier. Knowing how procurement and QA teams review a peptide API certificate of analysis helps buyers separate a complete, traceable record from a generic sheet of numbers. The COA should identify the material, lot, test methods, specifications, results, and authorization. It is a quality record, not a marketing brochure, so reviewers should expect consistent formatting and unambiguous data across lots.

Start with identity. The COA should state the peptide name, sequence or formula where applicable, molecular weight, and lot number. Reviewers compare these fields against the purchase specification and the supplier's own catalog description. Any mismatch in salt form, counterion, or acetate content deserves a written clarification. Because identity errors can cascade into formulation or analytical problems, procurement should not treat a polished COA as proof of conformity without checking that the stated identity matches the ordered material.

Purity data requires context. A high-performance liquid chromatography result should include the method, wavelength, column type, gradient, and integration criteria. A single purity percentage without method detail is difficult to interpret. QA reviewers look for a chromatogram or peak table that supports the reported value, plus a defined limit for unspecified impurities. Procurement teams can ask whether the method is stability-indicating and whether it has been transferred between sites.

Mass confirmation is another core element. Mass spectrometry results should show the expected molecular ion and a clear match to the theoretical mass. Reviewers check whether the reported mass accounts for adducts, salt form, or isotopic distribution. When the COA includes only a single numerical value, ask for the underlying spectrum or a summary of the interpretation. This is especially important for modified peptides, conjugates, or sequences with non-standard residues.

Counterion and residual content often determine whether a peptide fits a formulation. The COA may report acetate, trifluoroacetate, chloride, or water content, along with residual solvents and elemental impurities where relevant. QA teams compare these values to internal specifications and to compendial or regional expectations. Procurement should confirm that the supplier tests the same attributes on every lot and that methods are suitably validated for the intended use.